Tim Smith

An interview with Karan Lal on his experiences treating patients facing the rare condition known as epidermolysis bullosa.

An FDA announcement on this topical gene therapy for DEB pushes back the PDUFA date to May of this year, accompanying a regulatory update.

A recent study demonstrated that a combined treatment of topical corticosteroids and lebrikizumab led to reduced atopic dermatitis severity compared to the non-lebrikizumab group.

In her interview with HCPLive, Armstrong spoke on new data presented at Fall Clinical Dermatology on bimekizumab, deucravacitinib, and upadacitinib.

The sex differences, as well as other demographic differences, between GPP patients were assessed in a recent research letter.

A letter to the editor from China explored the various types of reactions to two types of vaccines for COVID-19.

A new study from Denmark explored the ineffectiveness associated with dupilumab in certain regions of the body after long-term examination.

A literature review summarized research on sesame allergies as the FDA begins labeling sesame as a major food allergen.

A set of highlights from some of the more impactful research and data covered this past week in the dermatology field, covering breakthroughs in research and advanced treatment options.

New research identified gene-corrected autologous keratinocyte grafts as useful for treating recessive DEB patients.

New research into students’ understanding of the dermatology field suggests greater knowledge and exposure may instill greater appreciation for it among medical students.

New data suggests occupational exposure to certain melanocytotoxic chemicals may lead to vitiligo.

In a summary of a symposium from the 2021 EADV Congress, the writers describe patients’ difficulties in living with psoriasis and adhering to treatments.

A recent study examined the increased rates of eczema on the hands of health workers more during the COVID-19 outbreak.

A recent study found that deucravacitinib saw positive results for moderate-to-severe adult plaque psoriasis patients.

Recent trial data showed positive results for B-VEC topical gene therapy treatment for dystrophic epidermolysis bullosa patients.

Allergic contact dermatitis burden many people, but it is important for patients to know why and how they may limit their risk.

An interview segment with Peter Young featuring a description of the response to the research into personal care product allergens.

A segment of an interview with Peter Young in which he describes his original interest in the subject of skincare product allergens.

A new study explored the topic of predictive biomarkers of clinical improvement of EASI scores for atopic dermatitis patients being given dupilumab.

Research on patients with generalized pustular psoriasis or erythrodermic psoriasis showed positive results for risankizumab.

A recent study highlighted psoriasis patients' lack of awareness of a link between psoriasis and obesity, as well as these same patients' hopes for future treatment programs targeting weight loss.

This newly-approved monoclonal antibody was developed as a citrate-free formulation of adalimumab.

New research into bimekizumab for psoriatic arthritis suggests the treatment to be effective for joint and skin improvements at 16 weeks.

An interview with Karan Lal, DO, regarding skincare product allergens, misdiagnosis of allergic contact dermatitis, and more.

New research indicated that the effects of sleep and physical activity deficiencies in low income youth were found to have an association with maladjustment.

Researchers have developed an automated hair loss measurement system for alopecia patients to track hair loss.

This year saw 4 new FDA approvals for the chronic condition. But dermatologists are still not satisfied.

A recent study presented at ASH 2022 examined the safety profiles of different hormonal contraceptives for female sickle cell disease patients at risk of thromboembolism.

New research presented at ASH 2022 and conducted following a Hemophilia-Related Distress Questionnaire indicated racial disparities between White and Black patients.